GENVEC INC Uncategorized Contracts & Agreements
22 Contracts & Agreements
- AMENDMENT NO. 1 TO RIGHTS AGREEMENT (Filed With SEC on January 24, 2017)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on May 10, 2016)
- SCHEDULE I SCHEDULE OF INVESTORS (Filed With SEC on March 18, 2014)
- 11.THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS (Filed With SEC on May 10, 2013)
- AMENDMENT NO. 1 TO SALARY CONTINUATIONAGREEMENT (Filed With SEC on March 22, 2013)
- EmploymentAgreement (Filed With SEC on May 24, 2012)
- BASICORDERING AGREEMENT # 10XS020 INTRODUCTION (Filed With SEC on November 9, 2010)
- LICENSEAGREEMENT (Filed With SEC on March 12, 2010)
- LICENSEAGREEMENT (Filed With SEC on March 12, 2010)
- SCHEDULEI SCHEDULEOF INVESTORS (Filed With SEC on January 27, 2010)
- Name of Investor: By: Name: Title: AGREED AND ACCEPTED: GENVEC, INC. By: Name: Title: 2 (Filed With SEC on June 6, 2008)
- GENVEC, INC. (Filed With SEC on June 6, 2008)
- GENVEC, INC. (Filed With SEC on June 6, 2008)
- OTHER TRANSACTION (OT) AGREEMENT OTHER TRANSACTION FOR PROTOTYPE AGREEMENT (Filed With SEC on May 10, 2007)
- Very truly yours, RODMAN & RENSHAW, LLC By: Name: Title: Address for notice: 1270 Avenue of the Americas, 16th Floor New York, NY, 10020 (Filed With SEC on December 20, 2006)
- - 1- - (Filed With SEC on August 8, 2005)
- - 1- - (Filed With SEC on August 8, 2005)
- TNFerade, which is currently in three Phase II trials for the treatment of locally advanced pancreatic cancer, non-metastatic esophageal cancer, and rectal cancer (Filed With SEC on March 15, 2004)
- TNFerade, which is currently in three Phase II trials for the treatment of locally advanced pancreatic cancer, non-metastatic esophageal cancer, and rectal cancer (Filed With SEC on March 15, 2004)
- TNFerade, which is currently in three Phase II trials for the treatment of locally advanced pancreatic cancer, non-metastatic esophageal cancer, and rectal cancer (Filed With SEC on March 15, 2004)
- TNFerade, which is currently in three Phase II trials for the treatment of locally advanced pancreatic cancer, non-metastatic esophageal cancer, and rectal cancer (Filed With SEC on March 15, 2004)
- AMENDMENT NO. 1 TO RIGHTS AGREEMENT (Filed With SEC on August 22, 2003)
